Status:
UNKNOWN
Evaluation of Atracurium-vecuronium Combination in Laparosocpic Surgery
Lead Sponsor:
Sir Ganga Ram Hospital
Conditions:
Patients Undergoing Laparoscopic Surgery
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Non-depolarising muscle relaxants are routinely employed to provide skeletal muscle relaxation during general anaesthesia (GA). Generally investigators use one or the other type of relaxant agent for ...
Detailed Description
The principal pharmacological effect of neuromuscular blocking drugs is to interrupt the transmission of nerve impulses at the neuromuscular junction. They are classified into depolarising (mimics the...
Eligibility Criteria
Inclusion
- ASA physical status I and II
- Laparoscopic surgeries likely to last for 1 hour duration
Exclusion
- Patient refusal
- ASA physical status III and IV
- History of hypersensitivity to atracurium or vecuronium
- Alcoholism and drug addiction
- Neuromuscular disorders
- Neuropsychiatric patients
- Hepatic and renal disease patients
- Obese patients
- Abnormal airway anatomy
- Risk of oesophageal reflux
Key Trial Info
Start Date :
December 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 25 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03371953
Start Date
December 20 2017
End Date
October 25 2018
Last Update
December 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, India, 110060